{ "items": [ "\n\n
Summary
\n \n\n \n \nSummary
\n \n\n \n \nThe Clinical Therapeutics Unit (CTU) conducts clinical studies on the treatment of uncomplicated malaria and analyses and models pathological responses in malaria, G6PD deficiency, vivax relapse and anti-infective drug pharmacometric and pharmacodynamics data.
\n \n\n \n \nSummary
\n \n\n \n \nSummary
\n \n\n \n \nThe Clinical Trials Support Group (CTSG) supports investigators conducting research for the MORU Tropical Health Network and in collaboration with MORU sister units in Vietnam and Kenya \u2013 an international endeavour both within Thailand and across Southeast Asia and Africa. Established in 2009, CTSG enhances the research infrastructure at MORU to ensure research is conducted to applicable Good Clinical Practice standards and regulations.
\n \n\n \n \nThe Mathematical and Economic MODelling (MAEMOD) Department\u2019s main research focus is mathematical and economic models supporting investigations into the transmission, control and elimination of tropical diseases.
\n \n\n \n \nPaying attention to the needs of the public and communities is essential to make our programmes ethical and trustworthy, and to maximise their success and impact.
\n \n\n \n \nEstablished in 2003 to meet a need for accurate, sensitive antimalarial drug measurements in the biological fluids of clinical trials patients, MORU\u2019s Department of Clinical Pharmacology is now one of the world\u2019s leading laboratories for antimalarial drug pharmacology.
\n \n\n \n \nThe aim of the Malaria & Critical Illness Department at MORU is to improve health through research that addresses threats arising from malaria for billions of people who live in malaria endemic zones around the globe.
\n \n\n \n \nMORU Epidemiology studies the factors that contribute to the risk of different diseases and how to reduce those risks. The research portfolio includes clinical studies, descriptive epidemiology, and statistical and mathematical modelling of human diseases in South and Southeast Asia and Africa with a current focus on malaria, dengue, novel pathogens and environmental health.
\n \n\n \n \nOpened in 1986, the Microbiology Department conducts research on: melioidosis, scrub typhus and other rickettsial infections; antimicrobial resistance; leptospirosis; the epidemiology of infectious diseases; sepsis and severe sepsis; the evaluation of diagnostic tests; and the immunology and cell biology of infectious diseases.
\n \n\n \n \nEstablished in 1979 as a research collaboration between Mahidol University (Thailand), Oxford University (UK) and the UK's Wellcome Trust, the Mahidol Oxford Tropical Medicine Research Unit (MORU) conducts targeted clinical trials and public health research that aim to discover and develop appropriate, affordable interventions that measurably improve the health of people living in resource-limited parts of the world.
\n \n\n \n \n